Gareth Pryce

Alıntı yapanlar

	Hepsi	2019 yılından bugüne
Alıntılar	10244	2906
h-endeksi	53	28
i10-endeksi	97	60

760

380

190

570

1987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202426 46 41 73 56 77 53 47 83 56 37 40 59 60 89 122 177 232 373 353 432 442 419 332 350 424 403 429 457 426 462 451 468 541 751 537 466 140

Genel erişim

Tümünü görüntüle

17 makale

0 makale

genel erişime açık olanlar

genel erişime açık olmayanlar

Finansman sağlayan kuruluşun getirdiği zorunluluğa dayalı olarak

Katkıda bulunan yazarlar

Gavin GiovannoniBarts and The London School of Medicine and Dentistrygiovannoni.net üzerinde doğrulanmış e-posta adresine sahip
Samuel JacksonUK Dementia Research Instituteukdri.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Vincenzo Di MarzoConsiglio nazionale delle Ricercheicb.cnr.it üzerinde doğrulanmış e-posta adresine sahip
Klaus SchmiererThe Blizard Institute, Queen Mary University of London, Medicine & Dentistry//Barts Health NHS Trustqmul.ac.uk üzerinde doğrulanmış e-posta adresine sahip
John GreenwoodHugh Davson Professor of Biomedical Research, University College London, Institute of Ophthalmologyucl.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Lopez-Ramirez M.A.University of California, San Diegoucsd.edu üzerinde doğrulanmış e-posta adresine sahip
Dr Mark C HirstVisiting fellow, Open University (Retired)open.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Washington LC dos-SantosPesquisador Titular, Fundação Oswaldo Cruzbahia.fiocruz.br üzerinde doğrulanmış e-posta adresine sahip
Tiziana BisognoRicercatore Istituto di Chimica Biomolecolare, CNRicb.cnr.it üzerinde doğrulanmış e-posta adresine sahip
Axel PetzoldUniversity College London, The National Hospital for Neurology and Neurosurgery & Moorfields Eyeucl.ac.uk üzerinde doğrulanmış e-posta adresine sahip
John W HuffmanClemson Universityclemson.edu üzerinde doğrulanmış e-posta adresine sahip
Christopher C. W. HughesUC Irvineuci.edu üzerinde doğrulanmış e-posta adresine sahip
Luigia CristinoInstitute of Biomolecular Chemistry of CNRicb.cnr.it üzerinde doğrulanmış e-posta adresine sahip
Maurizio BifulcoUniversity of Salernounisa.it üzerinde doğrulanmış e-posta adresine sahip
Eugene D. PonomarevAssоciate Professor, Department of Biology, School of Sciences and Humanities, Nazarbayev Universitynu.edu.kz üzerinde doğrulanmış e-posta adresine sahip
Alessia Ligrestiicb.cnr.it üzerinde doğrulanmış e-posta adresine sahip
Edith ChanUniversity College Londonucl.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Rickie PataniProfessor, MRC Senior Clinical Fellow & Consultant Neurologist @ The Francis Crick Institute & UCLucl.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Maria Grazia SpillantiniUniversity of Cambridgecam.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Benjamin J. WhalleyUniversity of Readingreading.ac.uk üzerinde doğrulanmış e-posta adresine sahip

Takip et

Gareth Pryce

Queen Mary University of London

qmul.ac.uk üzerinde doğrulanmış e-posta adresine sahip

Multiple Sclerosis


Başlık Alıntılara göre sırala Yıla göre sırala Başlığa göre sırala	Alıntı yapanlar Alıntı yapanlar	Yıl
Cannabinoids control spasticity and tremor in a multiple sclerosis model D Baker, G Pryce, JL Croxford, P Brown, RG Pertwee, JW Huffman, ... Nature 404 (6773), 84-87, 2000	802	2000
Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain L Cristino, L De Petrocellis, G Pryce, D Baker, V Guglielmotti, V Di Marzo Neuroscience 139 (4), 1405-1415, 2006	561	2006
The therapeutic potential of cannabis D Baker, G Pryce, G Giovannoni, AJ Thompson The Lancet Neurology 2 (5), 291-298, 2003	547	2003
Endocannabinoids control spasticity in a multiple sclerosis model D Baker, G Pryce, JL Croxford, P Brown, RG Pertwee, A Makriyannis, ... The FASEB journal 15 (2), 300-302, 2001	488	2001
In silico patent searching reveals a new cannabinoid receptor D Baker, G Pryce, WL Davies, CR Hiley Trends in pharmacological sciences 27 (1), 1-4, 2006	446	2006
Cannabinoids inhibit neurodegeneration in models of multiple sclerosis G Pryce, Z Ahmed, DJR Hankey, SJ Jackson, JL Croxford, JM Pocock, ... Brain 126 (10), 2191-2202, 2003	428	2003
Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB₁ on neurons and CB₂ on autoreactive T cells K Maresz, G Pryce, ED Ponomarev, G Marsicano, JL Croxford, LP Shriver, ... Nature medicine 13 (4), 492-497, 2007	426	2007
Lovastatin inhibits brain endothelial cell Rho-mediated lymphocyte migration and attenuates experimental autoimmune encephalomyelitis J Greenwood, CE Walters, G Pryce, N Kanuga, E Beraud, D Baker, ... FASEB journal: official publication of the Federation of American Societies …, 2003	298	2003
MicroRNA-155 negatively affects blood-brain barrier function during neuroinflammation. MA Lopez-Ramirez, D Wu, G Pryce, JE Simpson, A Reijerkerk, ... FASEB journal 28 (6), 2551-2565, 2014	268	2014
Memory B cells are major targets for effective immunotherapy in relapsing multiple sclerosis D Baker, M Marta, G Pryce, G Giovannoni, K Schmierer EBioMedicine 16, 41-50, 2017	256	2017
COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases D Baker, CAK Roberts, G Pryce, AS Kang, M Marta, S Reyes, K Schmierer, ... Clinical & Experimental Immunology 202 (2), 149-161, 2020	198	2020
Pharmacological foundations of cannabis chemovars MA Lewis, EB Russo, KM Smith Planta medica 84 (04), 225-233, 2018	197	2018
SV40 large T immortalised cell lines of the rat blood-brain and blood-retinal barriers retain their phenotypic and immunological characteristics J Greenwood, G Pryce, L Devine, DK Male, WLC dos Santos, VL Calder, ... Journal of neuroimmunology 71 (1-2), 51-63, 1996	188	1996
Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice. LG Bilsland, JR Dick, G Pryce, S Petrosino, V Di Marzo, D Baker, ... FASEB journal: official publication of the Federation of American Societies …, 2006	175	2006
Control of Spasticity in a Multiple Sclerosis Model is mediated by CB₁, not CB₂, Cannabinoid Receptors G Pryce, D Baker British journal of pharmacology 150 (4), 519-525, 2007	154	2007
Lymphocyte migration into brain modelled in vitro: control by lymphocyte activation, cytokines, and antigen D Male, G Pryce, C Hughes, P Lantos Cellular immunology 127 (1), 1-11, 1990	152	1990
Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis JM Anderson, DW Hampton, R Patani, G Pryce, RA Crowther, R Reynolds, ... Brain 131 (7), 1736-1748, 2008	150	2008
Inhibition of Rho GTPases with protein prenyltransferase inhibitors prevents leukocyte recruitment to the central nervous system and attenuates clinical signs of disease in an … CE Walters, G Pryce, DJR Hankey, SM Sebti, AD Hamilton, D Baker, ... The Journal of Immunology 168 (8), 4087-4094, 2002	144	2002
Antigen presentation in brain: MHC induction on brain endothelium and astrocytes compared. DK Male, G Pryce, CC Hughes Immunology 60 (3), 453, 1987	139	1987
Medicinal cannabis: is Δ⁹–tetrahydrocannabinol necessary for all its effects? JD Wilkinson, BJ Whalley, D Baker, G Pryce, A Constanti, S Gibbons, ... Journal of Pharmacy and Pharmacology 55 (12), 1687-1694, 2003	120	2003

Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.

Makaleler 1–20

Yıllık alıntı sayısı

Mükerrer alıntılar

Birleştirilmiş alıntılar

Katkıda bulunan yazar ekleKatkıda bulunan yazarlar

Takip et

Alıntı yapanlar

Katkıda bulunan yazarlar